Latest Cleo Diagnostics (ASX:COV) News
Page 2
Page 2 of 4
Cleo Diagnostics Advances FDA Submission and U.S. Reimbursement Pathway with A$6.2m Cash
29 July 2026
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Cleo Diagnostics Advances to Analytical Validation Ahead of FDA Submission
13 July 2026
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Cleo Diagnostics Sets U.S. Reimbursement Stage Ahead of FDA Nod
20 May 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Cleo Diagnostics Starts Manufacturing Program with Bio-Techne Ahead of FDA Submission
28 Apr 2026
Market Wrap - Week 14 (30 Mar -> 3 Apr) 2026
4 Apr 2026
Healthcare Wrap - Week 14 (30 Mar -> 3 Apr) 2026
4 Apr 2026
Cleo Diagnostics Hits Major Milestone in Ovarian Cancer Test Trial
31 Mar 2026
Healthcare Wrap - Week 13 (23 Mar -> 27 Mar) 2026
28 Mar 2026